Principal Financial Group Inc. lowered its stake in shares of Ingevity Co. (NYSE:NGVT – Get Rating) by 6.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 161,819 shares of the company's stock after selling 11,419 shares during the quarter. Principal Financial Group Inc. owned about 0.41% of Ingevity worth $10,367,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Advisor Group Holdings Inc. increased its holdings in Ingevity by 32.9% in the 4th quarter. Advisor Group Holdings Inc. now owns 3,668 shares of the company's stock valued at $264,000 after buying an additional 907 shares during the period. American Century Companies Inc. increased its holdings in Ingevity by 209.9% in the 4th quarter. American Century Companies Inc. now owns 20,044 shares of the company's stock valued at $1,437,000 after buying an additional 13,577 shares during the period. ProShare Advisors LLC increased its holdings in Ingevity by 37.9% in the 4th quarter. ProShare Advisors LLC now owns 14,849 shares of the company's stock valued at $1,066,000 after buying an additional 4,083 shares during the period. First Trust Advisors LP increased its holdings in Ingevity by 8.2% in the 4th quarter. First Trust Advisors LP now owns 51,757 shares of the company's stock valued at $3,711,000 after buying an additional 3,933 shares during the period. Finally, Raymond James & Associates increased its holdings in Ingevity by 16.3% in the 4th quarter. Raymond James & Associates now owns 40,228 shares of the company's stock valued at $2,884,000 after buying an additional 5,648 shares during the period. Institutional investors own 96.34% of the company's stock.
Get Ingevity alerts:Analyst Ratings Changes
Several equities research analysts have issued reports on the stock. StockNews.com raised shares of Ingevity from a "buy" rating to a "strong-buy" rating in a report on Friday, August 5th. TheStreet upgraded shares of Ingevity from a "c" rating to a "b-" rating in a research note on Friday, May 27th.
Ingevity Stock Performance
Shares of NYSE:NGVT opened at $73.43 on Thursday. The stock has a market capitalization of $2.85 billion, a P/E ratio of 19.74 and a beta of 1.85. Ingevity Co. has a 1-year low of $56.31 and a 1-year high of $83.65. The company has a current ratio of 2.54, a quick ratio of 1.50 and a debt-to-equity ratio of 1.80. The business has a 50-day moving average price of $66.18 and a two-hundred day moving average price of $65.60.Ingevity Company Profile
(Get Rating)
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats.
Further Reading
- Get a free copy of the StockNews.com research report on Ingevity (NGVT)
- 3 Payroll Software Makers Set For Growth In 2023
- PENN Entertainment Stock is Reset and Ready to Rebound
- NYSE Stocks Give Investors a Variety of Quality Options
- Zoom Video Communications Valuation Is Realigned With Reality
- The J.M. Smucker Company Proves Why Staples Are Outperforming
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Co. (NYSE:NGVT – Get Rating).
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.